DERMOVATE OINTMENT

País: Canadá

Língua: inglês

Origem: Health Canada

Compre agora

Ingredientes ativos:

CLOBETASOL PROPIONATE

Disponível em:

TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.

Código ATC:

D07AD01

DCI (Denominação Comum Internacional):

CLOBETASOL

Dosagem:

.05%

Forma farmacêutica:

OINTMENT

Composição:

CLOBETASOL PROPIONATE .05%

Via de administração:

TOPICAL

Unidades em pacote:

50G

Tipo de prescrição:

Prescription

Área terapêutica:

ANTI-INFLAMMATORY AGENTS

Resumo do produto:

Active ingredient group (AIG) number: 0110995001; AHFS:

Status de autorização:

APPROVED

Data de autorização:

2003-09-03

Características técnicas

                                Prescribing Information
Pr
DERMOVATE
®
Cream
(clobetasol propionate cream, USP)
Pr
DERMOVATE
®
Ointment
(clobetasol propionate ointment, USP)
Topical corticosteroid
TaroPharma
Preparation Date:
A Division of Taro Pharmaceuticals Inc.
Sept 02, 2003
130 East Drive
Brampton, Ontario
Revision Date:
L6T 1C1
August 6, 2003
Control # 086321
1
Prescribing Information
Pr
DERMOVATE
®
Cream
(clobetasol propionate cream, USP)
Pr
DERMOVATE
®
Ointment
(clobetasol propionate ointment, USP)
Topical Corticosteroid
Actions and Clinical Pharmacology
The corticosteroids are a class of compounds comprising steroid
hormones
secreted by the adrenal cortex and their synthetic analogs. In
pharmacologic
doses, corticosteroids are used primarily for their anti-inflammatory
and/or
immunosuppressive effects. Topical corticosteroids such as clobetasol
propionate are effective in the treatment of corticosteroid-responsive
dermatoses
primarily because of their anti-inflammatory, anti-pruritic, and
vasoconstrictive
actions. However, while the physiologic, pharmacologic and clinical
effects of the
corticosteroids are well known, the exact mechanisms of their actions
in each
disease are uncertain.
Clobetasol propionate has been shown to have topical and systemic
pharmacologic and metabolic effects characteristic of the
corticosteroid class of
drugs.
2
Indications and Clinical Use
DERMOVATE (clobetasol propionate) Cream and Ointment are indicated for
the
topical therapy of recalcitrant corticosteroid-responsive dermatoses,
including
severe cases of psoriasis (excluding widespread plaque psoriasis) and
eczematous dermatitis.
Contraindications
DERMOVATE (clobetasol propionate) cream and ointment are not indicated
for
the treatment of rosacea, acne vulgaris, perioral dermatitis or
perianal and genital
pruritus. These preparations are contraindicated also in the treatment
of primary
infected bacterial or fungal skin lesions if no anti-infective agent
is used
simultaneously, in primary cutaneous viral infections (i.e., herpes
simplex,
vaccinia and v
                                
                                Leia o documento completo
                                
                            

Pesquisar alertas relacionados a este produto